Search results for "Kidney neoplasms"

showing 10 items of 207 documents

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a mu…

2008

The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three bli…

Gadobutrol; Gadopentate dimeglumine; Renal lesions; MRI; Diagnostic differentiation; NoninferiorityGadolinium DTPAMalemedicine.medical_specialtyContrast MediaRenal lesionsSensitivity and SpecificityGadobutrollaw.inventionGadobutrolPrecontrastRandomized controlled trialmagnetic resonance contrast medialawmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingSingle-Blind Methodddc:610Neuroradiologymedicine.diagnostic_testbusiness.industryDiagnostic differentiationUltrasoundReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral MedicineNoninferiorityMiddle AgedImage EnhancementMagnetic Resonance ImagingKidney NeoplasmsClinical trialEuropeRadiology Nuclear Medicine and imagingFemaleGadopentate dimeglumineRadiologybusinessNuclear medicinemedicine.drugMRI
researchProduct

A multivariate statistical test for differential expression analysis

2022

AbstractStatistical tests of differential expression usually suffer from two problems. Firstly, their statistical power is often limited when applied to small and skewed data sets. Secondly, gene expression data are usually discretized by applying arbitrary criteria to limit the number of false positives. In this work, a new statistical test obtained from a convolution of multivariate hypergeometric distributions, the Hy-test, is proposed to address these issues. Hy-test has been carried out on transcriptomic data from breast and kidney cancer tissues, and it has been compared with other differential expression analysis methods. Hy-test allows implicit discretization of the expression profi…

Gene OntologyModels StatisticalMultidisciplinaryGene Expression ProfilingHumansBreast NeoplasmsFemaleKidney NeoplasmsScientific Reports
researchProduct

Karyotype analysis and marker chromosomes of renal cell carcinoma.

1988

Karyotyping was performed in 46 human renal cell carcinomas of various histological grades. Controls included chromosome analysis of normal renal parenchymal cells from the same patients. Various numerical chromosome aberrations were found as well as marker chromosomes. They are specific of the individual tumor but no single marker was identified occurring in all tumors tested. Only trisomy 3 was found in different tumors (31%), suggesting a more general character of this aberration. Histological dedifferentiation and large tumor size correlate with focusing of the karyotype towards distinct chromosomal modes indicative of distinct tumor cell subclones within these tumors. Their rapid growt…

Genetic MarkersPathologymedicine.medical_specialtyPoor prognosisbusiness.industryUrologyCellChromosomeKaryotypeTrisomymedicine.diseaseKidneyKidney Neoplasmsmedicine.anatomical_structureChromosome 3Renal cell carcinomaKaryotypingParenchymamedicineHumansRing ChromosomesHistological gradesChromosomes Human Pair 3businessCarcinoma Renal CellEuropean urology
researchProduct

Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.

1998

The stimulation of a specific immune response is an attractive goal in cancer therapy. Gene transfer of co-stimulatory molecules and/or cytokine genes into tumor cells and the injection of these genetically modified cells leads to tumor rejection by syngeneic hosts and the induction of tumor immunity. However, the development of host immune response could be either due to the introduced immunomodulatory genes or due to vector components. In this study, human renal cell carcinoma cell lines were modified by a retrovirus to express the co-stimulatory molecule B7-1 together with the hygromycin/thymidine kinase fusion protein (HygTk) as positive and negative selection markers. These B7-1-transd…

Genetic MarkersT cellGenetic VectorsLymphocyte ActivationHLA-B7 AntigenImmune systemRetrovirusAntigens NeoplasmGeneticsmedicineTumor Cells CulturedHumansMolecular BiologyCarcinoma Renal CellSelectable markerExpression vectorbiologyHistocompatibility Antigens Class IGene Transfer TechniquesGenetic TherapyAcquired immune systembiology.organism_classificationMolecular biologyKidney Neoplasmsmedicine.anatomical_structureRetroviridaeCell cultureThymidine kinaseCancer researchB7-1 AntigenMolecular MedicineT-Lymphocytes CytotoxicHuman gene therapy
researchProduct

Cytogenetic analysis of three primary Bellini duct carcinomas.

1996

Three Bellini duct carcinomas (BDC) of the kidney were cytogenetically analyzed after short-term culture. All three had clonal chromosome abnormalities: 91-92,XXY,-Y, +12, +12, -15, -16, -18, +mar (case 1); 53,XY, +2,t(2;7)(p22;q11), +der (2)t (2;7)(p22;q11), +3, +r(3),add(5)(p15), +7, -8, +12, +17, +r(17), +20, -21 (case 2); and 44-47,X,-Y, +9, +16, -21/46,XY. Some of the numerical abnormalities are shared with papillary renal cell carcinomas (PRCC)(+7, +12, +16, +17, and +20) but not with transitional renal cell carcinomas. The present findings support the previous notion that BDC are different from other types of RCC.

GeneticsAged 80 and overMaleCancer ResearchKidneyPapillary renal cell carcinomasCellBiologyAdenocarcinomaMiddle AgedMolecular biologySurvival AnalysisKidney NeoplasmsDiagnosis Differentialmedicine.anatomical_structureKaryotypingGeneticsmedicineHumansFemaleDuct (anatomy)Carcinoma Renal CellAgedNeoplasm StagingGenes, chromosomescancer
researchProduct

The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.

2003

HLA-G as a non-classical MHC class I molecule exhibits a limited tissue distribution and exerts multiple immune regulatory functions including the induction of immune tolerance. In addition, HLA-G has been detected in some tumors of different histology and therefore may represent a novel immune escape mechanism of tumor cells. Despite the immunogenicity of renal cell carcinoma (RCC), outgrowth of tumor cells occurs which might be attributable to abrogation of efficient anti-tumor responses. We here review the potential role of HLA-G in RCC immunology, the HLA-G expression pattern and its functional consequences on immune responses. A heterogenous constitutive and interferon- inducible HLA-G…

HLA-G AntigensCancer ResearchLymphokine-activated killer cellT cellmedicine.medical_treatmentHistocompatibility Antigens Class IHuman leukocyte antigenImmunotherapyBiologyFlow CytometryKidney NeoplasmsImmune toleranceImmunosurveillanceInterferon-gammamedicine.anatomical_structureImmune systemHLA AntigensHLA-GImmunologymedicineCancer researchHumansImmunotherapyRNA MessengerCarcinoma Renal CellSeminars in cancer biology
researchProduct

Loss of heterozygosity at the short arm of chromosome 3 in renal‐cell cancer correlates with the cytological tumour type

1993

A majority of renal-cell tumours retain heterozygosity at the short arm of chromosome 3. To investigate possible histopathological differences between tumours with and without such losses, we compared loss of heterozygosity data from 51 tumours with 1 histological and 2 different cytological classifications of renal-cell tumour. Using the cytological classification of Thoenes et al., we only found tumours with loss of heterozygosity in these authors' clear-cell category. Possibly, only these tumours arise by a mechanism of double loss of a tumour-suppressor gene on 3p, non-clear-cell renal tumours having a different genetic background. Alternatively, deletions may occur in all subtypes, in …

HeterozygoteCancer Researchmedicine.medical_specialtyPathologyMitotic crossoverCARCINOMAChromosome DisordersBiologyMOLECULAR ANALYSISLoss of heterozygosityGene duplicationmedicineHumansCarcinoma Renal CellSequence DeletionChromosome AberrationsDELETIONBreakpointCytogeneticsChromosomeCYTOGENETICSKidney NeoplasmsOncologyChromosome 3Clear cell carcinomaChromosomes Human Pair 3Polymorphism Restriction Fragment LengthInternational Journal of Cancer
researchProduct

Microwave-induced thermoablation with Amica-probe is a safe and reproducible method to treat solid renal masses: results from a phase I study.

2012

Microwave thermal ablation (MWTA) could be considered in the future for treating small solid renal masses. The aim of the present study was to determine both the tolerability of the new Amica-probe applicator-induced MWTA used in vivo on patients with solid renal masses and the effects of heating on renal tumors and normal renal parenchyma. Fourteen patients with renal masses eligible for open radical nephrectomy were enrolled in this phase I study. All patients underwent MWTA of renal masses during the open surgery procedure before clamping of renal vascular pedicle. The effects of MWTA on patients' coagulation and tumor/renal vasculature were investigated. The histological effects of MWTA…

HyperthermiaAblation TechniquesMaleCancer Researchmedicine.medical_specialtymicrowavemedicine.medical_treatmentNephrectomythermoablationminimally invasive treatmentFollow-Up StudieLesionmedicineAblation TechniqueHumansAdverse effectMicrowavesAgedAged 80 and overbusiness.industryCancerKidney NeoplasmReproducibility of ResultsGeneral MedicinePerioperativeEquipment DesignHyperthermia InducedMiddle Agedmedicine.diseaseAblationKidney NeoplasmsSurgeryClinical trialOncologyTolerabilityKidney neoplasms; Microwave; Minimally invasive treatment; ThermoablationFemaleRadiologymedicine.symptombusinessHumanFollow-Up StudiesOncology reports
researchProduct

Circulatory and metabolic responses of malignant tumors during localized hyperthermia

1980

The effect of localized hyperthermia on the circulatory responses and on the oxygen and glucose supply has been evaluated in tissue-isolated rat tumors utilizing an in situ perfusion system. On the average, localized hyperthermia caused a significant increase in total tumor blood flow after raising of the mean tumor temperature from 37 degrees C to 39.5 degrees C. At higher temperatures (42 degrees C) total tumor blood flow decreased to a level somewhat below the flow during normothermia. However, there were great interindividual differences in the response of blood flow to temperature. The changes in blood flow were paralleled by variations of the O2-consumption and of the glucose uptake o…

HyperthermiaCancer Researchmedicine.medical_specialtyHot TemperatureGlucose uptakeVasodilationBiologyMicrocirculationOxygen ConsumptionCarcinosarcomaInternal medicinemedicineAnimalsGeneral MedicineBlood flowmedicine.diseaseKidney NeoplasmsRatsRed blood cellGlucosemedicine.anatomical_structureEndocrinologyOncologyRegional Blood FlowAnesthesiaCirculatory systemVascular resistanceVascular ResistanceSarcoma ExperimentalNeoplasm TransplantationJournal of Cancer Research and Clinical Oncology
researchProduct

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2.

1996

Accessory function allows antigen-presenting cells to produce sufficient secondary signals for optimum T cell proliferation and interleukin-2 (IL-2) production. Alveolar macrophages are inferior accessory cells compared to monocytes (PBM). We report here that the accessory index (AI) of alveolar macrophages and PBM of patients with lung metastases of solid tumors treated with inhalations of human natural IL-2 (hnIL-2) increased following its administration (P0.005). The accessory index was significantly elevated from baseline values after 2 weeks of inhalation of 300,000 IU hnIL-2/day (8.2 +/- 10.2 compared to 1.1 +/- 1; P0.001). The inhalation of 150,000 IU also induced increases in the in…

Interleukin 2AdultCancer Researchmedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentImmunologyAntigen-Presenting CellsInternal medicineAdministration InhalationMacrophages AlveolarmedicineImmunology and AllergyHumansAntigen-presenting cellCarcinoma Renal CellAgedLungmedicine.diagnostic_testInhalationbusiness.industryMonocyteMiddle AgedKidney NeoplasmsEndocrinologyCytokineBronchoalveolar lavagemedicine.anatomical_structureCarcinoma BronchogenicOncologyEvaluation Studies as TopicImmunologyInterleukin-2Pulmonary alveolusbusinessBronchoalveolar Lavage Fluidmedicine.drugCancer immunology, immunotherapy : CII
researchProduct